Home Equities Score Why Atossa Therapeutics (ATOS) Is Surging 38% Pre-Market?

Why Atossa Therapeutics (ATOS) Is Surging 38% Pre-Market?

Before the ring of the bell today, Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company, has been seeing a 30.24% jump in its stock price. At the close of the previous session, the stock was up 16.43% to close at $2.48. Over the past 5 sessions, the stock is down -8.49% while the decline increases to -36.25% for the month. The stock has added 125.45% in the past year whereas its year-to-date performance stands at a gain of 161.05%.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

There has been no directly related news to drive that momentum, but the recent developments may also be an indicator of how the company is currently performing.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

Recent developments:

Atossa Therapeutics is dedicated to discovering and developing innovative drugs in the oncology and infectious disease fields. At present, the company is focusing its efforts on COVID-19 and breast cancer.

Last month, Atossa Therapeutics announced results from its Phase 1 double-blind, randomized, placebo-controlled clinical study using AT-301, Atossa’s proprietary nasal spray candidate.

  • A total of two different dose levels of AT-301 were tested over a 14-day period in healthy males and females in this study.
  • For newly diagnosed patients with COVID-19, AT-301 is being developed for at-home use.
  • Current FDA-approved treatments to treat COVID-19 cannot be used at home.
  • According to the studies’ final data analysis, no serious adverse events, no discontinuations, no bronchospasms were observed.
  • All subjects but one was observed to have adverse effects, which were found to be moderate in severity whereas all other adverse effects were milder.
  • AT-301 nasal spray was well tolerated in this study and was deemed safe by Atossa.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

  • AT-301 has been associated with nasal discomfort and sneezing as the most common treatment-related adverse events when administered in either a single or multiple doses.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Why did Corvus Pharmaceuticals Inc. (CRVS) stock soar on Wednesday?

Corvus Pharmaceuticals Inc. (CRVS) shares surged 9.17% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $2.38. in the regular...

Havertys Furniture Companies Inc. (HVT) stock gains during after-hour trading, Here’s to know why?

Havertys Furniture Companies Inc. (NASDAQ: HVT) stock declined by 0.39% at last close whereas the HVT stock price gains by 4.6% in the after-hours...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Why did Corvus Pharmaceuticals Inc. (CRVS) stock soar on Wednesday?

Corvus Pharmaceuticals Inc. (CRVS) shares surged 9.17% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $2.38. in the regular...

Antero Resources Corp. (AR) stock fell during after-market. Here’s to know why?

Antero Resources Corp. (NASDAQ: AR) stock plunged by 0.58% at last close while the AR stock price declines by 6.59% in the after-hours trading...

Why Electrameccanica Vehicles Corp. (SOLO) stock performed well on Wednesday?

Electrameccanica Vehicles Corp. (SOLO) shares gained 5.71% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $3.70 per share. in...

Related News

Antero Resources Corp. (AR) stock fell during after-market. Here’s to know why?

Antero Resources Corp. (NASDAQ: AR) stock plunged by 0.58% at last close while the AR stock price declines by 6.59% in the after-hours trading...

Virios Therapeutics Inc. (VIRI) stock fell during current market. What’s behind this?

Virios Therapeutics Inc. (NASDAQ: VIRI) stock price plunged by 1.46% in the current market trading session. Virios Therapeutics is a medical biotechnology firm focusing...

Infinity Pharmaceuticals Inc. (INFI) stock gains during pre-market. Let’s see why?

Infinity Pharmaceuticals Inc. (INFI) stock declined by 31.53% at the last close whereas the INFI stock price surges by 49.34% in the pre-market trading...

Sino-Global Shipping America Ltd. (SINO) stock surges during after-hour trading. Let’s find out why?

Sino-Global Shipping America Ltd. (SINO) stock plunged by 11.9% at last close whereas the SINO stock-price gains by 7.34% in the after-market. Sino-Global is founded...

Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?

Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam